Agile Therapeutics
AGRX
#10654
Rank
โ‚ฌ9.09 M
Marketcap
1,32ย โ‚ฌ
Share price
0.00%
Change (1 day)
320.60%
Change (1 year)

EPS for Agile Therapeutics (AGRX)

EPS in 2024 (TTM): -3,58ย โ‚ฌ

According to Agile Therapeutics 's latest financial reports the company's current EPS (TTM) is -3,37ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -206,62ย โ‚ฌ an increase over its 2021 EPS that were of -1.360ย โ‚ฌ.

EPS history for Agile Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-3,58ย โ‚ฌ
2022-206,62ย โ‚ฌ-84.81%
2021-1.360ย โ‚ฌ30%
2020-1.046ย โ‚ฌ53.85%
2019-680,08ย โ‚ฌ-32.76%
2018-1.011ย โ‚ฌ
2016-1.761ย โ‚ฌ-26.28%
2015-2.389ย โ‚ฌ21.79%
2014-1.962ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,62ย โ‚ฌ-325.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,14ย โ‚ฌ-133.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,10ย โ‚ฌ-191.92%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
-0,04360ย โ‚ฌ-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
0,30ย โ‚ฌ-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA